First-in-human Study of VE303 in Healthy Adult Volunteers

NCT04236778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: VE303
DRUG: Oral Vancomycin

Sponsor

Vedanta Biosciences, Inc.